{"entity":{"type":"insider","cik":"0001456615","url":"/insider/0001456615","json_url":"/insider/0001456615.json","name":"Greenberg Arthur","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":6,"first":"2011-06-17","last":"2016-01-07","span_basis":"filed_date"},"name_variants":[{"name":"Greenberg Arthur","source":"filing","n_filings":6,"first_seen":"2011-06-17","last_seen":"2016-01-07"}],"transactions":[{"id":2725434,"accession":"0001179022-16-000091","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179022-16-000091","line_url":"/filing/0001179022-16-000091#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001456615","owner_name":"Greenberg Arthur","owner_display_name":"Greenberg Arthur","owner_url":"/insider/0001456615","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1666.0,"shares_display":"1,666","price_per_share":1.72,"price_display":"1.72","price_state":"stated","total_value":2865.52,"total_display":"2,865.52","total_whole":"2,866","shares_owned_after":109445.0,"shares_owned_after_display":"109,445","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-05","filed_date":"2016-01-07","scope":"insider"},{"id":6746876,"accession":"0000914062-14-000230","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914062-14-000230","line_url":"/filing/0000914062-14-000230#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001456615","owner_name":"Greenberg Arthur","owner_display_name":"Greenberg Arthur","owner_url":"/insider/0001456615","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":4.56,"price_display":"4.56","price_state":"stated","total_value":4560.0,"total_display":"4,560.00","total_whole":"4,560","shares_owned_after":96667.0,"shares_owned_after_display":"96,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-19","filed_date":"2014-08-20","scope":"insider"},{"id":5096299,"accession":"0000914062-13-000330","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000914062-13-000330","line_url":"/filing/0000914062-13-000330#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001456615","owner_name":"Greenberg Arthur","owner_display_name":"Greenberg Arthur","owner_url":"/insider/0001456615","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":6.551,"price_display":"6.55","price_state":"stated","total_value":13102.0,"total_display":"13,102.00","total_whole":"13,102","shares_owned_after":95667.0,"shares_owned_after_display":"95,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-19","filed_date":"2013-11-19","scope":"insider"},{"id":2360283,"accession":"0001181431-12-041525","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-041525","line_url":"/filing/0001181431-12-041525#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001456615","owner_name":"Greenberg Arthur","owner_display_name":"Greenberg Arthur","owner_url":"/insider/0001456615","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.84,"price_display":"1.84","price_state":"stated","total_value":9200.0,"total_display":"9,200.00","total_whole":"9,200","shares_owned_after":94667.0,"shares_owned_after_display":"94,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-07-18","filed_date":"2012-07-20","scope":"insider"},{"id":3234320,"accession":"0001181431-12-024613","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-024613","line_url":"/filing/0001181431-12-024613#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001456615","owner_name":"Greenberg Arthur","owner_display_name":"Greenberg Arthur","owner_url":"/insider/0001456615","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":2.84,"price_display":"2.84","price_state":"stated","total_value":8520.0,"total_display":"8,520.00","total_whole":"8,520","shares_owned_after":89667.0,"shares_owned_after_display":"89,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-04-17","filed_date":"2012-04-18","scope":"insider"},{"id":9182116,"accession":"0001209191-11-035207","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-035207","line_url":"/filing/0001209191-11-035207#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001456615","owner_name":"Greenberg Arthur","owner_display_name":"Greenberg Arthur","owner_url":"/insider/0001456615","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":1.21,"price_display":"1.21","price_state":"stated","total_value":24200.0,"total_display":"24,200.00","total_whole":"24,200","shares_owned_after":75556.0,"shares_owned_after_display":"75,556","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-06-16","filed_date":"2011-06-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":6,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001133416","name":"GALECTIN THERAPEUTICS INC","url":"/issuer/0001133416","role":"Director","n_filings":6,"first_seen":"2011-06-17","last_seen":"2016-01-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001456615","retrieved_at":"2026-08-25T12:41:14+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}